These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Establishment and Characterization of MUi027-A: A Novel Patient-Derived Cell Line of Polycystic Kidney Disease with Linn AK; Maneepitasut W; Tubsuwan A; Kitiyanant N; Phakdeekitcharoen B; Borwornpinyo S; Hongeng S; Phanthong P J Pers Med; 2022 May; 12(5):. PubMed ID: 35629189 [TBL] [Abstract][Full Text] [Related]
30. Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease. Wu G; Tian X; Nishimura S; Markowitz GS; D'Agati V; Park JH; Yao L; Li L; Geng L; Zhao H; Edelmann W; Somlo S Hum Mol Genet; 2002 Aug; 11(16):1845-54. PubMed ID: 12140187 [TBL] [Abstract][Full Text] [Related]
31. Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD). Carrera P; Calzavara S; Magistroni R; den Dunnen JT; Rigo F; Stenirri S; Testa F; Messa P; Cerutti R; Scolari F; Izzi C; Edefonti A; Negrisolo S; Benetti E; Alibrandi MT; Manunta P; Boletta A; Ferrari M Sci Rep; 2016 Aug; 6():30850. PubMed ID: 27499327 [TBL] [Abstract][Full Text] [Related]
32. An autopsy case of subarachnoid hemorrhage due to ruptured cerebral aneurysm associated with polycystic kidney disease caused by a novel PKD1 mutation. Soejima M; Sugita Y; Koda Y Forensic Sci Int; 2014 Sep; 242():e18-e21. PubMed ID: 25022697 [TBL] [Abstract][Full Text] [Related]
33. Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations. Watnick T; He N; Wang K; Liang Y; Parfrey P; Hefferton D; St George-Hyslop P; Germino G; Pei Y Nat Genet; 2000 Jun; 25(2):143-4. PubMed ID: 10835625 [TBL] [Abstract][Full Text] [Related]
34. Mutational Screening of PKD1 and PKD2 Genes in Iranian Population Diagnosed with Autosomal Dominant Polycystic Kidney Disease. Ranjzad F; Tara A; Basiri A; Aghdami N; Moghadasali R Clin Lab; 2017 Jul; 63(7):1261-1267. PubMed ID: 28792715 [TBL] [Abstract][Full Text] [Related]
36. Human polycystin-2 transgene dose-dependently rescues ADPKD phenotypes in Pkd2 mutant mice. Li A; Tian X; Zhang X; Huang S; Ma Y; Wu D; Moeckel G; Somlo S; Wu G Am J Pathol; 2015 Oct; 185(10):2843-60. PubMed ID: 26435415 [TBL] [Abstract][Full Text] [Related]
37. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis. Li A; Fan S; Xu Y; Meng J; Shen X; Mao J; Zhang L; Zhang X; Moeckel G; Wu D; Wu G; Liang C J Cell Mol Med; 2017 Aug; 21(8):1619-1635. PubMed ID: 28244683 [TBL] [Abstract][Full Text] [Related]
38. Aberrant PKD2 splicing due to a presumed novel missense mutation in autosomal-dominant polycystic kidney disease. Tan YC; Blumenfeld J; Michaeel A; Donahue S; Balina M; Parker T; Levine D; Rennert H Clin Genet; 2011 Sep; 80(3):287-92. PubMed ID: 20950398 [TBL] [Abstract][Full Text] [Related]
39. Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on. Cornec-Le Gall E; Audrézet MP; Le Meur Y; Chen JM; Férec C Hum Mutat; 2014 Dec; 35(12):1393-406. PubMed ID: 25263802 [TBL] [Abstract][Full Text] [Related]
40. PKD1 mono-allelic knockout is sufficient to trigger renal cystogenesis in a mini-pig model. He J; Li Q; Fang S; Guo Y; Liu T; Ye J; Yu Z; Zhang R; Zhao Y; Hu X; Bai X; Chen X; Li N Int J Biol Sci; 2015; 11(4):361-9. PubMed ID: 25798056 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]